You are here: Home: Meet The Professors - Breast Cancer 2 | 2008: Faculty Affiliations and Disclosures

Faculty Affiliations

	Rowan T Chlebowski, MD, PhD Professor of Medicine David Geffen School of Medicine at UCLA Chief, Division of Medical Oncology and Hematology Harbor-UCLA Medical Center Torrance, California		Mark D Pegram, MD Director for Translational Research Program Braman Family Breast Cancer Research Institute UM Sylvester Comprehensive Cancer Center Miami, Florida
	Stephen E Jones, MD Medical Director, US Oncology Research and Co-Chair, Breast Cancer Research Committee US Oncology Research Houston, Texas Director, Breast Cancer Research Baylor-Sammons Cancer Center Dallas, Texas Texas Oncology, PA Dallas, Texas

Content Validation and Disclosures

Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Chlebowski — Consulting Agreements: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Novartis Pharmaceuticals Corporation, Pfizer Inc; Speakers Bureau: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation. Dr Jones — Consulting Agreements: Genentech BioOncology, GlaxoSmithKline, Pfizer Inc, Sanofi-Aventis; Speakers Bureau: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, GlaxoSmithKline, Pfizer Inc, Sanofi-Aventis. Dr Pegram — Advisory Committee: Amgen Inc, Bristol-Myers Squibb Company, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, Pfizer Inc; Speakers Bureau: Genentech BioOncology, GlaxoSmithKline, Sanofi-Aventis.

COMMUNITY PANEL — Drs Freedman, Hoffman and Levy had no real or apparent conflicts of interest to disclose. Dr Astrow — Consulting Agreement: Pfizer Inc. Dr De Fusco — Speakers Bureau: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation. Dr Farber — Stock Ownership: Celgene Corporation. Dr Gearhart — Speakers Bureau: Eli Lilly and Company, Sanofi-Aventis. Dr Kanner — Advisory Committee: AstraZeneca Pharmaceuticals LP, Celgene Corporation, Eisai Inc, Millennium: The Takeda Oncology Company. Dr Moss — Advisory Committee: Celgene Corporation, Millennium: The Takeda Oncology Company, Pharmion Corporation; Paid Research: Abraxis BioScience, Amgen Inc, Archimedes Development Limited, Eisai Inc, Genentech BioOncology, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, Pharmatech Inc, Sanofi-Aventis, Taiho Pharmaceutical Co Ltd. Dr Seigel — Stock Ownership: AstraZeneca Pharmaceuticals LP, Celgene Corporation, Genentech BioOncology, Millennium: The Takeda Oncology Company. Dr Vacirca — Speakers Bureau: Abraxis BioScience, OSI Oncology, Sanofi-Aventis. Dr Zelkowitz — Speakers Bureau: Pfizer Inc.

MODERATOR — Dr Love does not receive any direct remuneration from industry. Research To Practice receives funds in the form of educational grants to develop CME activities from the following commercial interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol-Myers Squibb Company, Celgene Corporation, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium: The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

Medical Oncologist Community Panel

Alan B Astrow, MD Director, Division of Medical Oncology/Hematology Maimonides Cancer Center Brooklyn, New York Patricia A De Fusco, MD Senior Staff Department of Medicine Hartford Hospital Hartford, Connecticut Bonni L Gearhart, MD Director, Oncology Education Overlook Hospital Summit, New Jersey Kenneth R Hoffman, MD, MPH Teaneck, New Jersey Steven P Kanner, MD Oncology Associates of South Florida Hollywood, Florida Isaac Levy, MD Memorial Hospital West Pembroke Pines, Florida

Leonard R Farber, MD Clinical Professor of Medicine Yale University School of Medicine Executive Director Hospital of Saint Raphael McGivney Cancer Center New Haven, Connecticut Robert A Moss, MD President, Medical Oncology Association of Southern California Private Practice Fountain Valley, California Leonard J Seigel, MD Bienes Cancer Center Fort Lauderdale, Florida Jeffrey L Vacirca, MD Assistant Professor of Medicine at University Hospital, Stony Brook North Shore Hematology/ Oncology Associates East Setauket, New York

Allan Freedman, MD Clinical Assistant Professor of Hematology-Oncology Department of Hematology- Oncology Emory University Atlanta, Georgia Suburban Hematology-Oncology Associates, PC Snellville, Georgia Richard S Zelkowitz, MD Chief, Section Heme/ Onc at Norwalk Hospital Medical Director Smillow Breast Health Center at Norwalk Hospital Clinical Affiliate/ Consultant at MSKCC Norwalk, Connecticut